https://www.thestar.com.my/aseanplus/aseanplus-news/2024/04/26/singapore-changi-airports-passenger-traffic-for-q1-2024-exceeds-pre-pandemic-levels

Singapore Changi Airport’s passenger traffic for Q1 2024 exceeds pre-pandemic levels.

Hopefully Genting Singapore doing well.

Don't give up yet.
If next month Singapore Genting result very good. GenB could break 5 again.
Just wait and hold.

Gambling Tax RM5 billion annually is more than the profit.
This RM5 billion is very important to Malaysia in order to pay minister gaji.

Government cannot close down Genting Berhad because Genting paying more than RM5 billion annually.

https://theedgemalaysia.com/node/709317

Don't have Casino in Johor is better for Genting. Less debt.
Genting have a lot of land in Johor. Good for Genting property.

https://theedgemalaysia.com/node/709317

SINGAPORE/KUALA LUMPUR (April 25): Malaysia is in early discussions with tycoons on opening a casino in Forest City, people familiar with the matter said, in a bid to revive the beleaguered US$100 billion (RM478.35 billion) property project that counts the country’s monarch as one of its shareholders.

Prime Minister Datuk Seri Anwar Ibrahim met Berjaya Corp Bhd founder Tan Sri Vincent Tan and Genting Group’s Tan Sri Lim Kok Thay last week at the development on the southern coast of Malaysia near Singapore, the people said, asking not to be identified because the information is private. His Majesty Sultan Ibrahim, King of Malaysia, was also represented, the people said.

From Annual Report.

The recent formalisation of the Johor-Singapore Special
Economic Zone and the revival of the High-Speed Rail
project augur well for the property market in Johor and
present good opportunities for our Group to further
realise the value of strategically located landbank
through well-executed property development activities.

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=232297&name=EA_DS_ATTACHMENTS

From Annual Report.

Our investments in life sciences companies such as
Genting TauRx Diagnostics Centre Sdn Bhd
(“GT Diagnostics”), TauRx Pharmaceuticals Ltd (“TauRx”),
Celularity Inc and DNAe Group Holdings Limited are at
various stages of research and development for new
treatments and ways to improve our health and lifestyle.
TauRx is pursuing regulatory interactions and submissions
for its oral anti-tau product, hydromethylthionine mesylate
to seek regulatory approval in the US, UK and other
territories.
GT Diagnostics announced in July 2023, the release of
HiPAL, a well-being app that empowers people to
conveniently monitor their cognitive health in the comfort
of their home. HiPAL is downloadable via Apple Store or
Google Play and is available in the US, UK, Malaysia, EU,
Singapore and Australia.
HiPAL Pro was released in August 2023 and is available
in the US market. This is a self-administered assessment
tool that aids the diagnosis and monitoring of dementia
in particular, Alzheimer's disease. HiPAL Pro was officially
listed with the US Food and Drug Administration as a
computerised cognitive assessment aid in July 2023.

TauRx was founded in 2002 in Singapore, with primary research facilities and operation based in Aberdeen, UK. The company has dedicated the past two decades to developing treatments and diagnostics for Alzheimer's and other neurodegenerative diseases due to protein aggregation pathology.

22 years is a very long time. Still pending

Hopefully Genting Singapore Q1 results very good. Follow will Genting Plantation and Genting Berhad. 5.20 sell all.

AKT, if TauRX next year only can approve, then I will sell first if price above 5.20. buy back when price drop below 4.70.

Why today down so much ?

Can someone please help to ask about TauRX status and latest update in AGM ?

AngTayKor, are you attending online AGM.

Bought 4.47 using today dividend money.

Their dividend payment % is fixed based on profit. Last year profit very good. Dividend % very good.
If this year profit down, dividend % will also go down.

Thailand not so soon, may take many years.
Genting Singapore have the chance to tender for the casino together with Thailand

Still no strong support. Too many seller at the end of the day. Buyer keep buying selling keep showing up.

AngTayKor,
HMTM is now available at HK under paid compassionate program. Taurx now applying to expand this program to other China territories like Macau guangdong region.

Can TauRX selling in China and south east Asia even without approval from FDA ?

I am looking at Bauto last 2 quarter results, actually the revenue and profit is getting lower last 2 quarter.
Any Idea how is the sales of Mazda car in Malaysia this quarter ?

Is our own mistake, even if next month the share price go up to 5, we also won't sell thinking of TauRX. Then later down again.
Nobody know when TauRX could approved.
It is sad to see the price up and down from 5 to 4.46 so many time.

Hoping Q1 2024 result no more impairment or one time write off.
If without the above result should be very good compare to last quarter and last year.
Then end of May 2024 can go back to RM5.

Genting boss need Viagra.
Up very slow, Down very fast.

Sikit Sikit lama jadi bukit.

bought 4.49
Good luck to me

ini kali lah

1.5 years too long. buay tahan.

Actually I feel that this is a good opportunities to buy now when market down due to WAR.
Too bad I still need to wait for another few more days for my Dividend.

AngTayKor,
My Taikor think its abt 75% chance for HMTM securing FDA AA after taking into account of the corrupted FDA else it would have been much higher chance.

Good. Sound good and confidence. Hopefully don't take too long.

TauRX - 6 months, 1 year, 2 years or just a dream ?
Too much money and time wasted.

Bursa Malaysia tumbles at open as inflation, Middle East tensions weigh

Is this could be a good opportunities to buy cheap ??????

Buy now and pray for Good Q1 2024 result.
1 month betting. Nobody know the result good or bad.

Go down more so I could buy more after getting dividend.

If it's not because of TauRX, I could have sold all at 5.00

Getting 9 cents dividend losing 40 cents in share price.
WTF .....LKT

AngTaykor the best person to replace lim
Too bad nobody have more share than lim.

They push down the price so next week with dividend money they could buy more.
Then later they will push up even higher.

Let's wait until next Friday.
The best thing to do now is Don't do anything.

https://www.nst.com.my/business/corporate/2024/04/1036993/genting-malaysia-strong-contender-new-york-city-new-casino

Genting Malaysia strong contender for New York City new casino license

Johnchew123
6 months I can wait.
Q1 results TP 5.40 ? Let 's pray hard hard. Good luck

Sime Darby got the Xpeng distribution in HK ?

TauRX next action item ?
TauRX dateline for approval?
When?

Friday 19 April 2024 Dividend day.
One week later CEO and Directors all cash rich buy low and sell high again.

https://www.nst.com.my/business/corporate/2024/03/1021303/maybank-ib-advises-investors-look-genting-given-its-involvement

Maybank IB advises investors to look at Genting given its involvement in life sciences

KUALA LUMPUR: Maybank Investment Bank (Maybank IB) is advising investors to explore opportunities in Genting Bhd's involvement in the life sciences sector via TauRx Pharmaceuticals Ltd.

This recommendation precedes TauRx Pharmaceuticals' unveiling of complete findings from its Phase 3 LUCIDITY trial of hydromethylthionine mesylate (HMTM), aimed at tackling Alzheimer's disease, scheduled for March 7.

"The company has started discussions with regulators in the UK and the US for product approval.

"In an optimistic scenario where the product is approved and TauRx is valued at US$15 billion with no discount, the target price for Genting could increase to RM9.40.

"Our estimates and RM5.73 target price remain the same, but we advise investors to buy now to position themselves early," it said.

However, TauRx claims that HMTM is effective in slowing cognitive decline and reducing brain atrophy, is safe without causing brain bleeding, and will be more affordable if approved because it can be taken orally instead of intravenously.

The life sciences company will present the 24-month data from its Phase 3 LUCIDITY trial of HMTM at the AD/PD 2024 Alzheimer's and Parkinson's Diseases Conference on March 7 in Lisbon, Portugal.

This presentation will include details of the final 12-month open-label phase of the trial, following the initial results reported throughout 2022.

Target price for Genting could increase to RM9.40.

https://theedgemalaysia.com/node/707281

Genting Malaysia pledges US$1b in taxes to win New York City casino licence.

April 8): The owner of the Resorts World casino in New York City said an expansion of its gambling offering there would lift its tax payment to the state to more than US$1 billion (RM4.75 billion) annually.

Genting Malaysia Bhd, which operates the resort in Queens, is seeking one of the three new casino licences officials are considering for the New York City area. The property paid more than US$600 million in taxes last year, according to a spokesman for the casino giant.

Genting Malaysia is pledging to continue paying the state about 67% of its slot machine revenue in taxes, an amount that includes administrative fees and other expenses. The share paid for table games like blackjack would be lower, but enough to get the overall annual tax contribution over the US$1 billion mark.

Genting Malaysia, which operates next to the Aqueduct race track, and MGM Resorts International, which runs the Empire City Casino in Yonkers, are considered strong contenders, because they already have facilities there. The new licences would allow them to expand their offerings, including blackjack, roulette and other table games.
New York has some of the country’s highest casino taxes with an effective 55% rate on electronic devices, according to the American Gaming Association trade group. Casinos in Nevada — where Genting Malaysia has a Las Vegas resort — pay 6.8%.

The progress of TauRX is too slow. No time line and no update on status and progress.

Every time MayBank analysis said something good about TauRX, they will push the price upsell at high price, then game over. I think MayBank got something to do with syndicate. The progress of TauRX is too slow, I will give GenB another 1 year. If still no progress, may sell all.

Just monitor TauRX progress.

AngTayKor, please provide us once you received any update on TauRX.
Very important. Do or die.

19 April Dividend. Reinvest.
End of May 2024 Q1 2024 result.

Bought 4.70. Good luck.

Set buy at 4.70.
Accumulate for long term.